ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ALX2004 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called ALX2004 in people with advanced lung, head and neck, colorectal, or esophageal cancers that have stopped responding to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a toxic payload directly to cancer …
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated May 26, 2026 09:10 UTC
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThis early-phase study tests whether a new drug called NRM-823 is safe and tolerable for people with advanced solid tumors that have not responded to other treatments. About 150 participants with cancers like lung, ovarian, or triple-negative breast cancer will receive NRM-823 al…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New combo therapy before surgery shows promise for esophageal cancer
Disease control Recruiting nowThis study tests a new approach for people with a type of esophageal cancer that has spread locally but not to distant organs. Participants receive a combination of immunotherapy and chemotherapy, followed by chemoradiation, and then surgery. The goal is to see if this sequence c…
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for advanced cancers: JAB-8263 enters human testing
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors or blood cancers that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 152 people will take part in this early-phase tr…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Simple blood test could catch deadly esophageal cancer early
Diagnosis Recruiting nowThis study aims to create a simple blood test to find esophageal cancer early, when it's easier to treat. Researchers will look at tiny particles in the blood from 600 adults with and without the disease. The goal is to replace invasive scopes with a quick, non-invasive screening…
Matched conditions: ESCC
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 08:34 UTC